期刊文献+

右美托咪定在老年患者腹腔镜胃癌术后的应用效果 被引量:2

Application effect of Dexmedetomidine on postoperative laparoscopic gastric cancer in elderly patients
下载PDF
导出
摘要 目的探讨右美托咪定在老年患者腹腔镜胃癌术后的应用效果。方法选取2016年1月~2017年12月在我院实施腹腔镜胃癌根治术的80例老年患者作为研究对象,根据随机信封法将其分为右美托咪定组(D组)与对照组(C组),每组各40例。D组患者在15 min内给予右美托咪定1μg/kg,之后以0.4μg/kg静脉泵注,C组患者在相同时间给予同等容积的生理盐水。所有患者均采用硬膜外麻醉复合全凭静脉麻醉,多模式术后镇痛。比较两组患者的手术时间、术中输液量、麻醉药用量、住院时间、术后恶心呕吐发生情况、术后炎性反应程度[C反应蛋白(CRP)、白介素-6(IL-6)、红细胞沉降率(ESR)、中性粒细胞百分比(N)]及术后功能恢复情况(PQRS)[情感模块(ED)、伤害性刺激模块(ND)、认知功能模块(CD)、整体术后功能恢复(OPR)]。结果两组患者的手术时间、术中输液量比较,差异无统计学意义(P>0.05);D组患者的丙泊酚、舒芬太尼用量均少于C组,住院时间短于C组,术后恶心呕吐发生率低于C组,差异有统计学意义(P<0.05)。两组患者术后各时间点的CRP及N比较,差异无统计学意义(P>0.05);D组患者术后各时间点的ESR、IL-6水平均低于C组,差异有统计学意义(P<0.05)。D组患者术后各时点的ED、ND、CD、OPR值均显著高于C组,差异有统计学意义(P<0.01)。结论右美托咪定在老年患者腹腔镜胃癌术后应用能明显减少患者麻醉药用量,缩短住院时间,减轻术后炎症反应,有利于术后功能恢复。 Objective To investigate the application effect of Dexmedetomidine on postoperative laparoscopic gastric cancer in elderly patients.Methods From January 2016 to December 2017,a total of 80 elderly patients who underwent laparoscopic radical gastrectomy for gastric cancer were selected as objects and divided into the Dexmedetomidine group(group D)and the control group(group C)according to the random envelope method,with 40 cases in each group.Group D received Dexmedetomidine 1μg/kg within 15 min,and then received that 0.4μg/kg,while group C received the same volume of physiological saline.All patients were anesthetized with epidural anesthesia combined with intravenous anesthesia and received postoperative multimodal analgesia.The operation time,intraoperative fluid volume,anesthetic dose,length of hospital stay,postoperative nausea and vomiting,postoperative inflammatory response(C-reactive protein[CRP],interleukin-6[IL-6],erythrocyte sedimentation rate[ESR],neutrophil percentage[N]),and postoperative functional recovery(PQRS)(emotive domain[ED],nociceptive domain[ND],cognitive domain[CD],overall postoperative function recovery[OPR])were compared between the two groups.Results There were no significant differences in the operation time and intraoperative fluid volume between the two groups(P>0.05).The doses of Propofol and Sufentanil in the group D were less than those in the group C,the hospital stay was shorter than that in the group C,the rate of postoperative nausea and vomiting was lower than that in the group C,and the differences were statistically significant(P<0.05).There were no significant differences in CRP and N at each time point after surgery between the two groups(P>0.05).The ESR and IL-6 levels at each time point after surgery in the group D were lower than those in the group C,and the differences were statistically significant(P<0.05).The values of ED,ND,CD and OPR at each time point after surgery in the group D were significantly higher than those in the group C,and the differences were statistically significant(P<0.01).Conclusion The application of Dexmedetomidine in elderly patients undergoing laparoscopic radical gastrectomy for gastric cancer can significantly reduce the dosage of anesthetic,shorten the hospitalization time,reduce the postoperative inflammatory response,and facilitate postoperative functional recovery.
作者 朱蓉 陈运良 王波 伍川 熊朝晖 ZHU Rong;CHEN Yun-liang;WANG Bo;WU Chuan;XIONG Zhao-hui(Department of Anesthesiology,West China-Guang′an Hospital,Sichuan University,People′s Hospital in Guang′an City,Sichuan Province,Guang′an 638001,China)
出处 《中国当代医药》 2018年第30期66-69,共4页 China Modern Medicine
关键词 右美托咪定 老年患者 多模式镇痛 术后加速康复 炎症反应 Dexmedetomidine Elderly patients Multimodal analgesia Enhanced recovery after surgery Inflammatory reaction
  • 相关文献

参考文献11

二级参考文献123

  • 1李民,张利萍,吴新民.右美托咪啶在临床麻醉中应用的研究进展[J].中国临床药理学杂志,2007,23(6):466-470. 被引量:483
  • 2佘守章,许学兵,李慧玲,吴戴红,莫世湟.右旋美托咪啶的镇静效应及其对国人颈内动脉血流量的影响[J].广东医学,2005,26(6):729-732. 被引量:23
  • 3叶平,邓世辉,陈彩霞,刘锦涛,徐克成.异丙酚静脉麻醉3种输注方式对无痛肠镜效果和安全性的比较[J].广东医学院学报,2007,25(4):400-402. 被引量:5
  • 4吴新民,许幸,王俊科,王鲲鹏,薛张纲,缪长虹,邓小明,艾登斌,于浩.静脉注射右美托咪啶辅助全身麻醉的有效性和安全性[J].中华麻醉学杂志,2007,27(9):773-776. 被引量:242
  • 5Afonsoa J, Reis F. Dexmedetomidine : current role in anesthesia and intensive care [ J ]. Rev Bras Artestesiol,2012,62 : 118 - 133.
  • 6Kohli U, Pandharipande EP, Muszkat M, et al. CYP2A6 genetic var- iation and dexmedetomidine disposition[ J]. Eur J Clin Pharmacol, 2012,68:937 - 942.
  • 7Fairbanks CA, Stone LS, Wilcox GL. Pharmacological profiles of al- pha 2 adrenergic receptor agonists identified using genetically altered mice and isobolographic analysis[ J]. Pharmacol Ther,2009,123 : 224 - 238.
  • 8Seyrek M, Halici Z,Yildiz O,et al. Interaction between dexmedeto- midine and alpha - adrenergic receptors: emphasis on vascular ac- tions[ J ] . J Cardiothorac Vasc Anesth,2011,25 :856 - 862.
  • 9Iirola T, Vilo S, Manner T, et al. Bioavailability of dexmedetomidine after intranasal administration[ J]. Eur J Clin Pharmaco1,2011,67 : 825 - 831.
  • 10Anttila M, Penttila J, Helminen A, et al. Bioavailability of dexme- detomidine after extravascular doses in healthy subjects [ J ]. Br J Clin Pharmacol,2003 ,56 :691 - 693.

共引文献236

同被引文献12

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部